Methods for Calling and Prioritzation of Somatic Variants from Panel, Exome and Genome Sequencing   
Dieter Beule, PhD, Berlin Institute of Health, Berlin, Germany

Validation of NGS Bioinformatics Pipelines: The AMP Working Group Guideline
Alexis B. Carter, MD, FCAP, FASCP, Children’s Healthcare of Atlanta, Atlanta, GA, USA

Molecular Pathology Informatics - Infrastructures and Toolsets for Distributed and Scalable Cancer Genomics in Clinical Practice   
Mark J. Routbort, MD, PhD, MD Anderson Cancer Center, Houston, TX, USA

ClinGen Allele Registry, Pathogenicity Calculator, and the Emerging Computational Knowledge Resources for Clinical Genomics
Aleksandar Milosavljevic, PhD, Baylor College of Medicine, Houston, TX, USA

Next Generation Sequencing and Leukemia Diagnosis
Manja Meggendorfer, MD, MBA, MML Munich Leukemia Laboratory, Munich, Germany

Impact of NGS Data on Lymphoma Classification, Diagnosis and Treatment
Ioannis Anagnostopoulos, MD, PhD, Charité Universitätsmedizin Berlin, Germany

Circulating Tumor Cells, Cell Free DNA, Liquid Biopsies    
Klaus Pantel, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

Targeted Sequencing in Small Tissue Biopsy Specimens
Mike Hubank, PhD, The Centre for Molecular Pathology, Royal Marsden Hospital, Surrey, United Kingdom

Immunotherapy From the Pathologist's Perspective (PD-L1)   
Janis M. Taube, MD, MSc, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Open Access PERSONAL Genomics and Epigenomics
Stephan Beck, PhD, FMedSci, University College London, London, United Kingdom

Oral presentations of selected abstracts.

Infectious and Heritable Disease Presentations

New Syndrome: First Patient with Heterozygous Deleterious PIG-Q Mutations Causing a GPI-anchor Biosynthesis Deficiency
Lois J. Starr (Omaha, USA)

Simultaneous Detection and Typing of Alpha, Beta and Gamma HPV Using Target Enrichment and Whole Genome Sequencing
Tengguo Li (Atlanta, USA)

Rapid Detection and Identification of Uveitis Pathogens by Qualitative Multiplex Real Time PCR followed by High Resolution Melting
Paulo J. M. Bispo (Boston, USA)

Oncology and Drug Resistance Presentations

Clinical Evaluation of a Novel NGS-Based HIV-1 Drug Resistance Monitoring Test
Charlie Lee (Singapore, Singapore)

Targeted Bisulfite NGS of a DNA-methylation Multimarker Panel for Cancers of the Urinary Tract in Liquid Biopsies
Stefan Karst (Berlin, Germany)

Detect 0.1% Low Frequency Somatic Variants in Cell-free DNA Using Oncomine^TM cfDNA Assays and Ion Torrent Sequencing
Jeff Schageman (Austin, USA)

Multi Institutional Evaluation of a High Sensitive NGS Assay for Liquid Biopsy Mutation Detection in Lung Cancer
Claudia Vollbrecht (Berlin, Germany)

Hematopathology Presentations

Small Customizable Next-Generation Sequencing Based Target Capture Panels in a Clinical Environment Can Detect Variant Mutations at Frequencies as Low as 0.5%
Lisa M. Chamberlain (San Diego, USA)

B- and T-Cell Immune Repertoire Characterization by Anchored Multiplex PCR and Next-Generation Sequencing
Jens Eberlein (Boulder, USA)

The Human Gastrointestinal Microbiome and Advances in Metagenomic Medicine
James Versalovic, MD, PhD,  Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA

Update on the Use of Human Gene Expression for the Diagnosis of Infectious Diseases
Gregory A. Storch, MD, Washington University School of Medicine, St. Louis, MO, USA

Quality Assurance in Pathology: The QuiP Experience
Manfred Dietel, University Hospital Charité, Berlin, Germany
 

Good or Bad Sequencing Data?  Setting a Benchmark for the Quality of NGS in the Diagnostic Lab
Simon Patton, PhD, European Molecular Genetics Quality Network (EMQN), Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, United Kingdom